Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Estropipate
Drug ID BADD_D00836
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D00948
MeSH ID C009927
PubChem ID 5284555
TTD Drug ID D03IUY
NDC Product Code 64918-0106; 12875-9998
UNII SVI38UY019
Synonyms estropipate | piperazine estrone sulfate | estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, compd. with piperazine (1:1) | Ogen | Harmogen | Genoral | Harmonet | Ortho-Est
Chemical Information
Molecular Formula C22H32N2O5S
CAS Registry Number 7280-37-7
SMILES CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O.C1CNCCN1
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Dermatitis23.03.04.002--Not Available
Dermatitis bullous23.03.01.002--
Dizziness24.06.02.007; 17.02.05.003; 02.11.04.006--
Dysmenorrhoea21.01.01.002--
Dyspareunia21.03.02.016; 19.08.05.004--
Dysuria20.02.02.002--
Ectropion of cervix21.06.01.004--Not Available
Embolism venous24.01.01.003--Not Available
Endometrial cancer21.07.02.002; 16.12.02.001--Not Available
Endometrial hyperplasia21.07.01.002--Not Available
Endometriosis21.07.01.004--Not Available
Epilepsy17.12.03.002--Not Available
Erythema23.03.06.001--Not Available
Erythema multiforme23.03.01.003; 10.01.03.015--
Erythema nodosum23.07.02.001; 10.02.01.020--Not Available
Fibrocystic breast disease21.05.04.018; 16.14.01.003--Not Available
Flatulence07.01.04.002--
Fluid retention20.01.02.003; 14.05.06.002--Not Available
Galactorrhoea21.05.02.002; 05.03.04.002--Not Available
Gallbladder disorder09.03.02.001--Not Available
Glucose tolerance decreased13.02.02.004--Not Available
Haemangioma24.03.06.004; 16.02.01.002--Not Available
Haemangioma of liver24.03.06.006; 16.06.01.003; 09.04.01.003--Not Available
Headache17.14.01.001--
Hepatic function abnormal09.01.02.001--Not Available
Hirsutism23.02.04.001; 05.05.01.005--
Hypercalcaemia14.04.01.003; 05.04.01.002--
Hyperglycaemia14.06.02.002; 05.06.02.002--
Hypernatraemia14.05.04.001--
Hypersensitivity10.01.03.003--
The 2th Page    First    Pre   2 3 4 5    Next   Last    Total 5 Pages